 | • レポートコード：MRC-IM30418 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の調査レポートによると、世界の体外診断市場規模は2021年に980.7億ドルに達しました。今後、2027年には1,415.8億ドルになり、2022年から2022年の間に年平均6.20％成長すると予測しています。本調査レポートでは、体外診断の世界市場について調査・分析を行い、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、検査種類別（臨床化学、分子診断、免疫診断、血液、その他）分析、製品別（試薬＆キット、機器）分析、使用別（使い捨て、再利用可能）分析、用途別（感染症、糖尿病、がん腫瘍、心臓、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを掲載しています。なお、企業情報には、Abbott Laboratories, Agilent Technologies Inc., Biomerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, Illumina Inc., Qiagen N.V, Quest Diagnostics, Shimadzu Corporation, Siemens Healthcare GmbH and Sysmex Corporation.などが含まれています。 ・序論 ・調査範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界の体外診断市場規模：検査種類別 - 臨床化学検査の市場規模 - 分子診断検査の市場規模 - 免疫診断検査の市場規模 - 血液検査の市場規模 - その他検査の市場規模 ・世界の体外診断市場規模：製品別 - 試薬＆キットの市場規模 - 機器の市場規模 ・世界の体外診断市場規模：使用別 - 使い捨て体外診断の市場規模 - 再利用可能体外診断の市場規模 ・世界の体外診断市場規模：用途別 - 感染症用体外診断の市場規模 - 糖尿病用体外診断の市場規模 - がん腫瘍用体外診断の市場規模 - 心臓用体外診断の市場規模 - その他用途の市場規模 ・世界の体外診断市場規模：地域別 - 北米の体外診断市場規模 - アジアの体外診断市場規模 - 欧州の体外診断市場規模 - 中南米の体外診断市場規模 - 中東・アフリカの体外診断市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global in vitro diagnostics market size reached US$ 98.07 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 141.58 Billion by 2027, exhibiting a growth rate (CAGR) of 6.20% during 2022-2027.
In vitro diagnostics (IVD) are tests carried out on blood or tissue samples taken from the human body. They are used to monitor the overall health of patients for curing, treating and preventing diseases. They help reduce hospital stays as IVD can produce instant results of samples for better diagnostic decisions. They allow multiple tests at the same time for screening for the presence of drugs in patients. In addition, they assist healthcare professionals in recording data of patients in the form of a photocopy and scanned images.
In Vitro Diagnostics Market Trends:
At present, there is a rise in the demand for IVD devices for immunodiagnostics, tissue and molecular diagnostics, and hematology across the globe. This, along with the burgeoning healthcare industry, represents one of the key factors propelling the market. Besides this, the rising prevalence of chronic diseases, such as tuberculosis (TB), cancer, heart disease, stroke, diabetes, and arthritis, are contributing to the growth of the market. In addition, the development of automated IVD systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnoses are offering lucrative growth opportunities to industry investors. Moreover, key market players are investing in research and development (R&D) to introduce IVD products with molecular diagnostic capabilities for delivering effective and accurate results. They are also focusing on launching tests for home-based testing, which is positively influencing the market. Apart from this, there is an increase in the geriatric population around the world. This, coupled with technological advancements in IVD devices, such as portability, accuracy, and cost-effectiveness, is offering a positive market outlook. Additionally, the rising awareness among the masses about the benefits of IVD systems is bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global in vitro diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on test type, product, usability, application and end user.
Breakup by Test Type:
Clinical Chemistry
Molecular Diagnostics
Immunodiagnostics
Hematology
Others
Breakup by Product:
Reagents and Kits
Instruments
Breakup by Usability:
Disposable IVD Devices
Reusable IVD Devices
Breakup by Application:
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Others
Breakup by End User:
Hospitals Laboratories
Clinical Laboratories
Point-of-care Testing Centers
Academic Institutes
Patients
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Biomerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, Illumina Inc., Qiagen N.V, Quest Diagnostics, Shimadzu Corporation, Siemens Healthcare GmbH and Sysmex Corporation.
Key Questions Answered in This Report:
How has the global in vitro diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global in vitro diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the usability?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global in vitro diagnostics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global In Vitro Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Test Type
6.1 Clinical Chemistry
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Molecular Diagnostics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunodiagnostics
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Hematology
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Product
7.1 Reagents and Kits
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Instruments
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Usability
8.1 Disposable IVD Devices
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Reusable IVD Devices
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Infectious Disease
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diabetes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cancer/Oncology
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Cardiology
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Autoimmune Disease
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Nephrology
9.6.1 Market Trends
9.6.2 Market Forecast
9.7 Others
9.7.1 Market Trends
9.7.2 Market Forecast
10 Market Breakup by End User
10.1 Hospitals Laboratories
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinical Laboratories
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Point-of-care Testing Centers
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Academic Institutes
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Patients
10.5.1 Market Trends
10.5.2 Market Forecast
10.6 Others
10.6.1 Market Trends
10.6.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Agilent Technologies Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Biomerieux SA
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Bio-Rad Laboratories Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 F. Hoffmann-La Roche Ltd
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 SWOT Analysis
16.3.6 Fujifilm Holdings Corporation
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Illumina Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Qiagen NV
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Quest Diagnostics
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Shimadzu Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Siemens Healthcare GmbH
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Sysmex Corporation
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
Figure 2: Global: In Vitro Diagnostics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: In Vitro Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: In Vitro Diagnostics Market: Breakup by Test Type (in %), 2021
Figure 5: Global: In Vitro Diagnostics Market: Breakup by Product (in %), 2021
Figure 6: Global: In Vitro Diagnostics Market: Breakup by Usability (in %), 2021
Figure 7: Global: In Vitro Diagnostics Market: Breakup by Application (in %), 2021
Figure 8: Global: In Vitro Diagnostics Market: Breakup by End User (in %), 2021
Figure 9: Global: In Vitro Diagnostics Market: Breakup by Region (in %), 2021
Figure 10: Global: In Vitro Diagnostics (Clinical Chemistry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: In Vitro Diagnostics (Clinical Chemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: In Vitro Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: In Vitro Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: In Vitro Diagnostics (Immunodiagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: In Vitro Diagnostics (Immunodiagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: In Vitro Diagnostics (Hematology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: In Vitro Diagnostics (Hematology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: In Vitro Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: In Vitro Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: In Vitro Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: In Vitro Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: In Vitro Diagnostics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: In Vitro Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: In Vitro Diagnostics (Disposable IVD Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: In Vitro Diagnostics (Disposable IVD Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: In Vitro Diagnostics (Reusable IVD Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: In Vitro Diagnostics (Reusable IVD Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: In Vitro Diagnostics (Infectious Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: In Vitro Diagnostics (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: In Vitro Diagnostics (Diabetes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: In Vitro Diagnostics (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: In Vitro Diagnostics (Cancer/Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: In Vitro Diagnostics (Cancer/Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: In Vitro Diagnostics (Cardiology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: In Vitro Diagnostics (Cardiology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: In Vitro Diagnostics (Autoimmune Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: In Vitro Diagnostics (Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: In Vitro Diagnostics (Nephrology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: In Vitro Diagnostics (Nephrology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: In Vitro Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: In Vitro Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: In Vitro Diagnostics (Hospitals Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: In Vitro Diagnostics (Hospitals Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: In Vitro Diagnostics (Clinical Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: In Vitro Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: In Vitro Diagnostics (Point-of-care Testing Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: In Vitro Diagnostics (Point-of-care Testing Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: In Vitro Diagnostics (Academic Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Global: In Vitro Diagnostics (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Global: In Vitro Diagnostics (Patients) Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Global: In Vitro Diagnostics (Patients) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Global: In Vitro Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Global: In Vitro Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: North America: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: North America: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United States: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United States: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Canada: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Canada: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Asia-Pacific: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Asia-Pacific: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: China: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: China: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Japan: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Japan: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: India: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: India: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: South Korea: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: South Korea: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Australia: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Australia: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Indonesia: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Indonesia: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Europe: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Europe: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Germany: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Germany: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: France: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: France: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: United Kingdom: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: United Kingdom: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Italy: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Italy: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Spain: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Spain: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Russia: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Russia: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Others: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Latin America: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Latin America: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Brazil: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Brazil: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Mexico: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Mexico: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Others: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 99: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 100: Middle East and Africa: In Vitro Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 101: Middle East and Africa: In Vitro Diagnostics Market: Breakup by Country (in %), 2021
Figure 102: Middle East and Africa: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 103: Global: In Vitro Diagnostics Industry: SWOT Analysis
Figure 104: Global: In Vitro Diagnostics Industry: Value Chain Analysis
Figure 105: Global: In Vitro Diagnostics Industry: Porter's Five Forces Analysis
• 日本語訳：体外診断の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30418 ▷ お問い合わせ（見積依頼・ご注文・質問）